Therapeutics MD Is Urging Women to ‘Take Pause’ During Menopause Awareness Month
TherapeuticsMD, Inc. (NASDAQ: TXMD) is recognizing Menopause Awareness Month to empower the 64 million U.S. women currently in menopause. With over 80% experiencing symptoms, the company highlights vulvar and vaginal atrophy (VVA), affecting more than half of menopausal women. The 'Take Pause' initiative includes educational videos featuring Dr. Rebecca Brightman to raise awareness about VVA and available treatments such as IMVEXXY. This effort aims to normalize discussions around menopause and its symptoms, encouraging women to seek care.
- Initiating the 'Take Pause' educational campaign aimed at increasing awareness of menopause and its symptoms.
- Involving healthcare professionals to educate women about vulvar and vaginal atrophy (VVA) and treatment options.
- Encouraging discussions around menopause, potentially expanding the market for related products.
- None.
September is Menopause Awareness month, and
In the next ten years, there will be more than 1.2 billion women worldwide in menopausei
More than
Many people are aware of common menopause symptoms like hot flashes, which impact
“While women today are prioritizing their health more than ever before, menopause continues to be misunderstood and is rarely discussed,” said
As part of the Take Pause initiative,
-
The educational video series will feature Dr.
Rebecca Brightman , Board-Certified OBGYN and Menopause Specialist, discussing vulvar and vaginal atrophy, which causes painful sex. - The pausable and shareable social ads encourage people to learn more about menopause and some of its bothersome symptoms like painful sex. The messaging brings awareness to a stage of a woman’s life that continues to be ignored by society.
Through the Take Pause initiative and our recent Long May She REIGN Campaign,
IMVEXXY (estradiol vaginal inserts) Important Risk Information
USE
IMVEXXY is a prescription medicine that contains an estrogen hormone in a vaginal insert. It is used after menopause to treat moderate to severe painful intercourse, a symptom of changes in and around your vagina, due to menopause.
IMPORTANT RISK INFORMATION
MOST IMPORTANT INFORMATION YOU SHOULD KNOW ABOUT IMVEXXY (an estrogen hormone)
- Using estrogen-alone may increase your chance of getting cancer of the uterus (womb).
- Report any unusual vaginal bleeding right away while you are using IMVEXXY. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb). Your healthcare provider should check any unusual vaginal bleeding to find out the cause.
- Do not use estrogen-alone or with progestins to prevent heart disease, heart attacks, strokes, or dementia (decline of brain function).
- Using estrogen-alone or with progestin may increase your chances of getting strokes or blood clots.
- Using estrogen-alone or with progestins may increase your chance of getting dementia, based on a study of women 65 years of age or older.
- Using estrogens with progestins may increase your chances of getting heart attacks or breast cancer.
- Talk to your doctor regularly about whether you still need treatment with IMVEXXY.
DO NOT USE IF YOU
- have unusual vaginal bleeding.
- currently have or have had certain cancers.
- currently have or have had blood clots.
- had a stroke or heart attack.
- currently have or have had liver problems.
- have been diagnosed with a bleeding disorder.
- are allergic to IMVEXXY or any of its ingredients.
- think you may be pregnant.
WARNINGS
Tell your healthcare provider about all of your medical conditions, including if you:
- have any unusual vaginal bleeding.
- have asthma (wheezing), epilepsy (seizures), diabetes, migraine, endometriosis, lupus, angioedema (swelling of face and tongue), problems with your heart, liver, thyroid, kidneys, or have high calcium levels in your blood.
- are going to have surgery or will be on bed rest. You may need to stop using IMVEXXY.
- are breast feeding.
Tell your healthcare provider about all the medicines you take.
IMVEXXY may affect the way other medicines work, and other medicines may affect how IMVEXXY works.
WHEN USING IMVEXXY YOU
- headache
- breast tenderness or pain
- nausea and vomiting
The risk information provided here is not complete. To learn more, talk about IMVEXXY with your healthcare provider or pharmacist. The FDA-approved product labeling can be found at IMVEXXY.com/pi.pdf.
BIJUVA® (estradiol and progesterone) Important Risk Information
IMPORTANT RISK INFORMATION
Most important information you should know about BIJUVA (a combination of estrogen and progestogen):
- Do not use estrogens with or without progestogens to prevent heart disease, heart attacks, strokes, or dementia (decline of brain function).
- Using estrogens with progestogens may increase your chances of getting heart attacks, strokes, breast cancer, or blood clots.
- Using estrogens with progestogens may increase your chance of getting dementia, based on a study of women 65 years of age and older.
- Using estrogen-alone may increase your chance of getting cancer of the uterus.
- Do not use estrogen-alone to prevent heart disease, heart attacks, strokes, or dementia (decline of brain function).
- Using estrogen-alone may increase your chances of getting strokes or blood clots.
- Using estrogen-alone may increase your chance of getting dementia, based on a study of women 65 years of age and older.
- You and your healthcare provider should talk regularly about whether you still need treatment with BIJUVA.
DO NOT USE BIJUVA IF YOU
- Have had your uterus (womb) removed (hysterectomy). BIJUVA contains a progestogen to decrease the chance of getting cancer of the uterus. If you do not have a uterus, you do not need a progestogen and you should not use BIJUVA.
- Have any unusual vaginal bleeding. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb). Your healthcare provider should check any unusual vaginal bleeding to find out the cause.
- Have been diagnosed with a bleeding disorder.
- Have or have had certain cancers. Estrogens may increase the chances of getting certain types of cancers, including cancer of the breast or uterus. If you have or have had cancer, talk with your healthcare provider about whether you should use BIJUVA.
- Have or have had blood clots.
- Had a stroke or heart attack.
- Have or have had liver problems.
- Are allergic to BIJUVA or any of its ingredients.
WARNINGS
Ask a doctor before use if you:
- Have high levels of fat in your blood (triglycerides).
- Have any unusual vaginal bleeding.
- Have any other medical conditions that may become worse while you are using BIJUVA, such as: asthma (wheezing); diabetes; a genetic problem called porphyria; lupus; hypertension (high blood pressure); have high calcium in your blood; epilepsy (seizures); migraine; endometriosis; angioedema (swelling of face or tongue); problems with your heart, liver, thyroid or kidneys.
- Are going to have surgery or will be on bed rest.
- Are pregnant or think you may be pregnant. BIJUVA is not for pregnant women.
- Are breastfeeding.
Tell your doctor or pharmacist about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
WHEN USING BIJUVA, YOU
● Breast tenderness ● Headache ● Vaginal bleeding ● Vaginal discharge ● Pelvic pain
Call your doctor right away if you get any of the following warning signs:
- New breast lumps
- Unusual vaginal bleeding
- Changes in vision or speech
- Sudden new severe headaches
- Severe pains in your chest or legs with or without shortness of breath, weakness and fatigue
- Vomiting
USE
BIJUVA is a prescription medicine that contains two hormones, an estrogen and a progestogen. BIJUVA is used after menopause to reduce moderate to severe hot flashes in women with a uterus.
The risk information provided here is not complete. To learn more, review the BIJUVA Patient Information and talk about BIJUVA with your healthcare provider or pharmacist. The FDA-approved product labeling, including Patient Information, can be found at BIJUVA.com/pi.pdf.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088. You may also report side effects to
About
Forward-Looking Statements
This press release by
i Sussman et al. Prevalence of menopausal symptoms among mid-life women: findings from medical records. BMC Women’s Health. 2015 15:58. doi: 10.1186/s12905-015-0217-y.
ii Wysocki S, Kingsberg S, Krychman M. Management of vaginal atrophy: implications from the REVIVE survey.
iii Goodman NF, Cobin RH, Ginzburg SB, Katz IA, Woode DE;
iv
TXMD-20060
View source version on businesswire.com: https://www.businesswire.com/news/home/20210902005272/en/
212-452-2793
lwilson@insitecony.com
Source:
FAQ
What is the focus of TherapeuticsMD's Menopause Awareness Month initiative?
How many women in the U.S. are currently in menopause according to TherapeuticsMD?
What product is highlighted in TherapeuticsMD's Menopause Awareness Month efforts?
Who is featured in the educational videos for the Take Pause initiative?